News EU regulators back J&J's Zytiga in early prostate cancer use New use could give J&J drug edge over Pfizer's rival
News Robots don't improve prostate surgery outcomes, says study No differences found in urinary function, post-operative complications or days off work.
News NICE lifts restrictions on Ferring prostate cancer drug Decision followed a successful appeal by manufacturer.
Views & Analysis Pharma gets social: did digital opinion leaders shape NICE g... Digital Opinion Leaders as activists in healthcare decision making.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
